本页面由Tiger Trade Technology Pte. Ltd.提供服务

Redhill Biopharma Ltd

0.5150
-0.0184-3.46%
盘后:0.5020-0.0130-2.52%19:49 EDT
成交量:8.21万
成交额:4.21万
市值:313.17万
市盈率:-3.79
高:0.5334
开:0.5145
低:0.5000
收:0.5335
52周最高:2.14
52周最低:0.4351
股本:608.09万
流通股本:608.09万
量比:0.03
换手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-0.1358
每股收益(LYR):-0.1358
净资产收益率:-1708.61%
总资产收益率:-22.37%
市净率:-2.90
市盈率(LYR):-3.79

数据加载中...

2026/04/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/26

SEC问询函

Form CORRESP - Correspondence
2026/01/22

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/01/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/12/31

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/06/30

SEC问询函

Form CORRESP - Correspondence
2025/06/25

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/04/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC问询函

Form CORRESP - Correspondence
2024/06/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/08

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

SEC问询函

Form CORRESP - Correspondence
2024/02/09

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/26

SEC问询函

Form CORRESP - Correspondence
2023/08/10

SEC问询函

Form CORRESP - Correspondence